Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications

PURPOSE: Deletions of chromosome 1 have been described in 7-40% of cases of myeloma with inconsistent clinical consequences. CDKN2C at 1p32.3 has been identified in myeloma cell lines as the potential target of the deletion. We tested the clinical impact of 1p deletion and used high resolution techn...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Leone, Paola E., Walker, Brian A., Jenner, Matthew W., Chiecchio, Laura, Dagrada, GianPaolo, Protheroe, Rebecca K.M., Johnson, David C., Dickens, Nicholas J., Brito, Jose Luis, Else, Monica, Gonzalez, David, Ross, Fiona M., Chen-Kiang, Selina, Davies, Faith E., Morgan, Gareth J.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2008
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2581792/
https://ncbi.nlm.nih.gov/pubmed/18829482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0347
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים